Testing the Vsling device for heart failure repair
Part of Heart & circulation clinical trials.
This trial tests a new device called Vsling™ that helps reshape the heart's main pumping chamber (left ventricle) in people with heart failure. The goal is to improve heart function and reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 84 years old.
- Your heart's pumping strength (ejection fraction) is between 20% and 40%.
- Your left ventricle (main pumping chamber) is enlarged, at least 55mm wide when relaxed.
- You have mild or no mitral valve leakage (grade 2+ or less).
- You have not had a dangerous heart rhythm or cardiac surgery in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called Vsling, which is placed inside the heart to help reshape the main pumping chamber (left ventricle) in people with heart failure. It may improve your heart's strength and reduce symptoms like shortness of breath.
This study tests a new heart implant called the Ventura IASD in people with weakened heart pumping (low ejection fraction). The goal is to see if it helps relieve symptoms and improve quality of life in patients with chronic heart failure.
This trial tests a less invasive procedure to reshape the heart in people with heart failure due to a scar or aneurysm. It aims to improve heart function and symptoms.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This study tests a new device called the Vesalius TMVr system to fix a leaky mitral valve without open-heart surgery. It's for people with severe mitral regurgitation who are not good candidates for surgery.
This trial tests a new device called V-Lap that is placed in the heart to monitor pressure. It may help doctors better manage heart failure and reduce hospital stays. Researchers want to see if it works well in people with mild to moderate heart failure.
Hear when a new HFrEF - Heart Failure with Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.